ASTRAZEN Income Statement - TTM - AstraZeneca Pharma India Limited

Income Statement (TTM)

AstraZeneca Pharma India Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	8,218	7,982	8,136	7,954	7,836	7,839	8,056	8,625	9,009	9,502	10,030	10,661	11,410	11,970	12,955	13,876	14,845	16,190	17,163	18,551
Change (%)		-2.87	1.92	-2.23	-1.48	0.04	2.77	7.07	4.45	5.47	5.55	6.29	7.03	4.91	8.23	7.11	6.99	9.06	6.01	8.09
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	3,176	3,045	3,010	2,949	2,976	3,070	3,169	3,338	3,401	3,539	3,660	3,932	4,286	4,856	6,008	7,206	8,244	9,232	9,688	10,338
Change (%)		-4.10	-1.15	-2.02	0.92	3.14	3.23	5.34	1.87	4.06	3.42	7.43	9.01	13.30	23.71	19.95	14.40	11.98	4.94	6.71
% of Revenue	38.64	38.15	37.00	37.08	37.98	39.16	39.34	38.70	37.74	37.24	36.49	36.88	37.56	40.57	46.37	51.94	55.54	57.02	56.45	55.73

Gross Operating Profit	5,043	4,937	5,125	5,004	4,860	4,769	4,887	5,287	5,609	5,964	6,370	6,729	7,124	7,114	7,010	6,669	6,601	6,958	7,475	8,213
Change (%)		-2.10	3.82	-2.36	-2.89	-1.87	2.48	8.19	6.09	6.32	6.81	5.64	5.87	-0.15	-1.46	-4.85	-1.03	5.42	7.43	9.88
% of Revenue	61.36	61.85	63.00	62.92	62.02	60.84	60.66	61.30	62.26	62.76	63.51	63.12	62.44	59.43	54.11	48.06	44.46	42.98	43.55	44.27

SG&A	2,196	2,245	2,226	2,236	2,231	2,279	2,345	2,483	2,552	2,647	2,608	2,567	2,633	2,709	3,329	2,496	2,602	2,536	2,596	2,700
Change (%)		2.24	-0.83	0.43	-0.21	2.14	2.91	5.85	2.78	3.74	-1.48	-1.56	2.57	2.90	22.87	-25.01	4.23	-2.54	2.39	3.99
% of Revenue	26.72	28.13	27.37	28.11	28.48	29.08	29.11	28.78	28.32	27.86	26.00	24.08	23.08	22.63	25.70	17.99	17.53	15.66	15.13	14.55

R&D
Change (%)
% of Revenue

OpEx	7,240	7,067	6,973	6,923	6,980	7,127	7,362	7,807	7,953	8,233	8,541	8,772	9,403	10,176	11,260	12,454	13,482	14,262	15,015	16,099
Change (%)		-2.38	-1.33	-0.72	0.83	2.11	3.30	6.03	1.87	3.52	3.75	2.70	7.19	8.22	10.66	10.61	8.25	5.78	5.28	7.22
% of Revenue	88.09	88.54	85.71	87.04	89.07	90.92	91.39	90.51	88.27	86.64	85.16	82.28	82.40	85.01	86.92	89.76	90.82	88.09	87.48	86.78

Operating Income	979	915	1,163	1,031	856	712	694	819	1,057	1,270	1,489	1,889	2,008	1,795	1,714	1,421	1,363	1,928	2,148	2,452
Change (%)		-6.50	27.07	-11.30	-16.96	-16.90	-2.52	18.02	29.07	20.16	17.26	26.92	6.28	-10.61	-4.48	-17.09	-4.12	41.50	11.39	14.14
% of Revenue	11.91	11.46	14.29	12.96	10.93	9.08	8.61	9.49	11.73	13.36	14.84	17.72	17.60	14.99	13.23	10.24	9.18	11.91	12.52	13.22

Interest Expense	-11	-11	-11	-11	-11	-10	-10	-9	-8	-8	-6	-6	-9	-14	-12	-12	-10	-7	-15	-21
Change (%)		-0.97	-0.99	-0.73	-2.76	-3.16	-6.76	-8.39	-9.70	-3.92	-16.57	-5.19	56.52	44.52	-11.18	-3.33	-13.79	-29.00	105.63	41.78
% of Revenue	-0.14	-0.14	-0.13	-0.14	-0.13	-0.13	-0.12	-0.10	-0.09	-0.08	-0.06	-0.06	-0.08	-0.11	-0.09	-0.08	-0.07	-0.04	-0.09	-0.11

Net Income	813	756	933	849	705	609	616	715	921	1,100	993	1,330	1,528	1,393	1,616	959	819	970	1,157	1,834
Change (%)		-6.95	23.41	-8.99	-16.95	-13.66	1.17	16.09	28.83	19.41	-9.75	33.95	14.89	-8.84	16.01	-40.68	-14.54	18.37	19.36	58.42
% of Revenue	9.89	9.47	11.47	10.68	9.00	7.77	7.65	8.29	10.23	11.58	9.90	12.48	13.39	11.64	12.47	6.91	5.52	5.99	6.74	9.88

Source: Capital IQ

AstraZeneca Pharma India Limited - Income Statement (TTM)

Income Statement (TTM)

Other Listings